Chronic low back pain is common but not often a focus for prevention, experts say. Just getting more steps in a day could ...

Contineum anticipates topline data from the PIPE-791 Phase 1b chronic pain study in early 2026. “We’re pleased to expand PIPE-791 clinical development to include the potential treatment of ...

In a new study, two therapies eased pain and reduced opioid use in people with chronic low back pain, even after years of ...

New York, USA, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Chronic Pain Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 20+ Companies Working in the Domain ...

A new molecule developed by University at Buffalo researchers acts like a local, long-lasting anesthetic, providing robust ...

About 40% of adults with chronic pain had clinical symptoms of depression and anxiety. Around 37% met the diagnostic criteria for major depressive disorder, and 16.7% met criteria for generalized ...

The clinical guidelines were published in the Annals of Internal Medicine. At present, no cannabinoids have been approved for treating chronic pain. Patients can nevertheless legally access cannabis ...

Chronic lower back pain is one of the top complaints that ... Now, there’s hope on the horizon for these patients. Early clinical trial results indicate a new antibiotic drug could treat ...

The presenting clinical manifestations during the early stage ... A teenager or a young adult presenting with chronic back pain and stiffness that worsens with prolonged inactivity is a typical ...

In her new book, “Mind Your Body: A Revolutionary Program to Release Chronic Pain and Anxiety ... problems than the physical manifestations of pain — because they’re not easy to solve.

In fact, many studies exclude people who with chronic pain who have depression or anxiety from clinical trials. We need integrated treatments that address chronic pain and mental health together ...